Stockscreener 앱 받기
1.23
4.65%
-0.06
시간 외 거래:
1.24
0.01
+0.81%
전일 마감가:
$1.29
열려 있는:
$1.29
하루 거래량:
1.48M
Relative Volume:
0.78
시가총액:
$87.46M
수익:
$391.70K
순이익/손실:
$-52.34M
주가수익비율:
-1.64
EPS:
-0.75
순현금흐름:
$-45.92M
1주 성능:
-3.91%
1개월 성능:
+147.83%
6개월 성능:
+144.82%
1년 성능:
+7.89%
1일 변동 폭
$1.17
$1.33
1주일 범위
$1.16
$1.34
52주 변동 폭
$0.2425
$1.47
Ovid Therapeutics Inc Stock (OVID) Company Profile
명칭
Ovid Therapeutics Inc
전화
212-776-4381
주소
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
OVID을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OVID
Ovid Therapeutics Inc
|
1.23 | 91.73M | 391.70K | -52.34M | -45.92M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-08 | 재개 | B. Riley Securities | Buy |
| 2024-06-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-04-30 | 개시 | B. Riley Securities | Buy |
| 2024-04-29 | 개시 | H.C. Wainwright | Buy |
| 2024-04-05 | 개시 | Wedbush | Outperform |
| 2023-12-21 | 개시 | BTIG Research | Buy |
| 2023-10-13 | 개시 | Oppenheimer | Outperform |
| 2021-04-20 | 다운그레이드 | Cantor Fitzgerald | Buy → Neutral |
| 2021-03-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2018-04-20 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Ovid Therapeutics Inc 주식(OVID)의 최신 뉴스
Is Ovid Therapeutics Inc. subject to activist investor interestJuly 2025 Action & Weekly Setup with ROI Potential - خودرو بانک
Can swing trading help recover from Ovid Therapeutics Inc. lossesPortfolio Gains Report & Safe Entry Zone Identification - Newser
Smart tools for monitoring Ovid Therapeutics Inc.’s price actionWeekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Real time social sentiment graph for Ovid Therapeutics Inc.July 2025 Macro Moves & Daily Growth Stock Tips - Newser
Neurology biopharmas rebound on trial catalysts and Q2 gains - BioWorld MedTech
Using Bollinger Bands to evaluate Ovid Therapeutics Inc.2025 Volume Leaders & Community Consensus Trade Signals - Newser
Is Ovid Therapeutics Inc. forming a bottoming basePortfolio Risk Report & Comprehensive Market Scan Insights - Newser
What indicators show strength in Ovid Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Will a bounce in Ovid Therapeutics Inc. offer an exitOptions Play & Step-by-Step Trade Execution Guides - Newser
Can machine learning forecast Ovid Therapeutics Inc. recovery2025 Price Momentum & Reliable Volume Spike Trade Alerts - Newser
What MACD signals say about Ovid Therapeutics Inc.Market Activity Summary & Low Risk High Win Rate Stock Picks - Newser
Using Ichimoku Cloud for Ovid Therapeutics Inc. technicalsPortfolio Growth Summary & Accurate Buy Signal Notifications - Newser
How to track smart money flows in Ovid Therapeutics Inc.Quarterly Market Review & Smart Allocation Stock Tips - Newser
Why is Ovid Therapeutics Inc. stock going upChart Signals & Community Consensus Trade Alerts - خودرو بانک
Custom watchlist performance reports with Ovid Therapeutics Inc.Stock Surge & AI Driven Price Predictions - Newser
Building trade automation scripts for Ovid Therapeutics Inc.July 2025 Review & High Conviction Investment Ideas - Newser
Will Ovid Therapeutics Inc. price bounce be sustainableM&A Rumor & Fast Entry High Yield Stock Tips - Newser
How hedge fund analytics apply to Ovid Therapeutics Inc. stockBuy Signal & Breakout Confirmation Trade Signals - Newser
What hedge funds are buying Ovid Therapeutics Inc.Weekly Profit Summary & High Accuracy Investment Signals - خودرو بانک
Multi asset correlation models including Ovid Therapeutics Inc.Profit Target & AI Based Trade Execution Alerts - Newser
Visualizing Ovid Therapeutics Inc. stock with heatmapsJuly 2025 Final Week & Pattern Based Trade Signal System - Newser
Full technical analysis of Ovid Therapeutics Inc. stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - Newser
What recovery options are there for Ovid Therapeutics Inc.Sell Signal & Weekly Return Optimization Plans - Newser
Multi factor analysis applied to Ovid Therapeutics Inc.Market Risk Analysis & Stock Portfolio Risk Management - Newser
Key resistance and support levels for Ovid Therapeutics Inc.2025 Trading Recap & Low Risk High Reward Ideas - Newser
Ovid Therapeutics Reports Increased Revenue Amid Challenges - MSN
Investment Review: Is Ovid Therapeutics Inc. forming a breakout patternJuly 2025 Update & Free Risk Controlled Daily Trade Plans - خودرو بانک
Is it too late to sell Ovid Therapeutics Inc.Weekly Trading Summary & Stock Portfolio Risk Management - Newser
Ovid Therapeutics Inc. stock volume spike explainedTrade Risk Summary & Daily Stock Trend Watchlist - Newser
Analyzing Ovid Therapeutics Inc. with multi timeframe chartsWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
Does Ovid Therapeutics Inc. fit your quant trading modelWeekly Loss Report & Fast Moving Trade Plans - Newser
Quantitative breakdown of Ovid Therapeutics Inc. recent moveRate Cut & Weekly High Potential Stock Alerts - Newser
Ovid Therapeutics Inc. recovery potential after sell offTrade Exit Summary & Weekly High Return Forecasts - Newser
Ovid Therapeutics Inc (OVID) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ovid Therapeutics Inc 주식 (OVID) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rona Jeffrey A | CBFO |
Feb 26 '25 |
Sale |
0.56 |
3,902 |
2,185 |
67,973 |
| ALEXANDER MARGARET A. | President and COO |
Jan 27 '25 |
Buy |
0.73 |
6,810 |
4,971 |
34,935 |
1.40%
자본화:
|
볼륨(24시간):